EBRO 2017

Conclusion (5bis)

• Concomitant CRT is standard (level 1) • platinum-based doublet • CT added to RT increases acute toxicity (level 1) • no applicable to unfit patients • Survival benefit is relatively small (level 1) • What about new drugs ?????